Furlanetto, J., Marmé, F., & Loibl, S. (2022). Sacituzumab govitecan: past, present and future of a new antibody-drug conjugate and future horizon: Drug evaluation. Future oncology, 18(28), . https://doi.org/10.2217/fon-2022-0407
Chicago-Zitierstil (17. Ausg.)Furlanetto, Jenny, Frederik Marmé, und Sibylle Loibl. "Sacituzumab Govitecan: Past, Present and Future of a New Antibody-drug Conjugate and Future Horizon: Drug Evaluation." Future Oncology 18, no. 28 (2022). https://doi.org/10.2217/fon-2022-0407.
MLA-Zitierstil (9. Ausg.)Furlanetto, Jenny, et al. "Sacituzumab Govitecan: Past, Present and Future of a New Antibody-drug Conjugate and Future Horizon: Drug Evaluation." Future Oncology, vol. 18, no. 28, 2022, https://doi.org/10.2217/fon-2022-0407.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.